Drug Type Nanobody |
Synonyms- |
Target |
Mechanism TNFRSF3 agonists(Tumor necrosis factor receptor superfamily member 3 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | - | 09 Jan 2024 | |
Solid tumor | Discovery | - | 09 Jan 2024 | |
Solid tumor | Discovery | - | 09 Jan 2024 |